http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15359560

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Research Support, Non-U.S. Gov't
endingPage 764
issn 1432-0843
0344-5704
issueIdentifier 4
pageRange 751-764
publicationName Cancer Chemotherapy and Pharmacology
startingPage 751
bibliographicCitation Tolcher AW, Appleman LJ, Shapiro GI, Mita AC, Cihon F, Mazzu A, Sundaresan PR. A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 2010 Jun 03;67(4):751–64. doi: 10.1007/s00280-010-1372-3.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f50b0cf6a94b94167ce42a9da1cb448
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cbf876e86721fab55b4a5377faf73e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9070cd2ed82f2cdd33a007a498feeac2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e863e8ef9959503e609339333914781f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c873640518537509bb52c133f1a8f435
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c8cb12696a3b7bf959791df1e91d285
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6fa4eb849909b35294df7b8699771dc
date 2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20521052
https://doi.org/10.1007/s00280-010-1372-3
https://pubmed.ncbi.nlm.nih.gov/PMC3064895
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664
https://portal.issn.org/resource/ISSN/0344-5704
https://portal.issn.org/resource/ISSN/1432-0843
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
discusses http://id.nlm.nih.gov/mesh/M0016578
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0446095
http://id.nlm.nih.gov/mesh/M0014833
http://id.nlm.nih.gov/mesh/M0002336
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129321892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129911295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128033392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128206212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128132375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136293705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128424170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129144708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135774423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129307185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129364554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244491953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128048219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245369624

Total number of triples: 63.